# Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision

> **NCT01795209** · PHASE4 · TERMINATED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 19 (actual)

## Conditions studied

- Branch Retinal Vein Occlusion
- Macular Edema

## Interventions

- **DRUG:** Ranibizumab
- **DEVICE:** Sham injection
- **PROCEDURE:** Rescue laser

## Key facts

- **NCT ID:** NCT01795209
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** insufficient enrollment
- **Last updated:** 2019-09-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01795209

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01795209, "Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01795209. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*